Immunotech Laboratories Inc (IMMB)

[Dodgeball]

This sheds some light on who owns whats, provided the deal came to fruition.

From the EPCO/$ENZC September 30,2017 Quarterly...

On March 9, 2017, theCompany entered into an agreement with the shareholders of Immunotech Laboratories, Inc. (Immunotech) to acquire all of the outstanding shares, both preferred and common stock. The 60,000,000 million Immunotech Series A preferred shares are being exchanged one for one for the Newly Created ECPO Preferred Series A with the exact same voting preference as the Immunotech Series A preferred. Immunotech’s 200 Million outstanding Series B Preferred are being exchanged two for one but do have a voting preferenceand shall be exchanged for 100 Million Series B Preferred shares of ECPO with the exact same voting preferences as the Immunotech Series B Preferred. The Company will issue 291,578,947series B preferred in exchange of 574,964,967 of common stock of Immunotech. This transaction is still in process. Currently the Company has acquired voting control and majority ownership of Immunotech Laboratories, Inc. At the effective time of the Acquisition, all options to acquire common stock of Immunotech issued and outstanding, whether vested or unvested, shall automatically be converted into and become options to purchase shares of Common Stock. Upon conversion of the Newly Created ECPO series B the shareholders of IMMB participating in the Share Exchange Agreement will own 80% of the issued and outstanding of ECPO. No common stock of ECPO will be issued until the Newly Created Preferred Series B is Converted.

September 30,2017 Quarterly